Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7739 | 1255 | 27.0 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
126 | 23061 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//MYCOPHENOLIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION | Author keyword | 13 | 80% | 1% | 8 |
2 | DUAL ORGAN TRANSPLANTATION | Author keyword | 6 | 80% | 0% | 4 |
3 | COMBINED TRANSPLANTATION | Author keyword | 3 | 50% | 0% | 5 |
4 | HEART KIDNEY TRANSPLANTATION | Author keyword | 3 | 100% | 0% | 3 |
5 | INTERDISCIPLINARY LIVER TRANSPLANT UNIT | Address | 3 | 40% | 0% | 6 |
6 | ADULT HLTH POST PROGRAM | Address | 2 | 44% | 0% | 4 |
7 | BAYLOR TRANSPLANT SCI | Address | 2 | 67% | 0% | 2 |
8 | CARDIAC ALLOGRAFT RECIPIENTS | Author keyword | 2 | 67% | 0% | 2 |
9 | CNI TOXICITY | Author keyword | 2 | 67% | 0% | 2 |
10 | COMBINED HEART AND KIDNEY TRANSPLANT | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHRONIC RENAL DYSFUNCTION | 32 | 70% | 2% | 26 |
2 | SINGLE DONOR ALLOGRAFTS | 21 | 90% | 1% | 9 |
3 | CALCINEURIN INHIBITORS | 16 | 12% | 10% | 127 |
4 | GLOMERULAR ABNORMALITIES | 15 | 88% | 1% | 7 |
5 | MELD ERA | 13 | 55% | 1% | 16 |
6 | CYCLOSPORINE NEPHROTOXICITY | 11 | 21% | 4% | 45 |
7 | SIROLIMUS CONVERSION | 10 | 73% | 1% | 8 |
8 | CHRONIC NEPHROPATHY | 10 | 26% | 3% | 33 |
9 | NONRENAL ORGAN | 10 | 63% | 1% | 10 |
10 | STANDARD DOSE TACROLIMUS | 9 | 83% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Use of Sirolimus in Liver Transplant Recipients with Renal Insufficiency: A Systematic Review and Meta-Analysis | 2010 | 27 | 25 | 60% |
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation | 2013 | 39 | 101 | 18% |
Calcineurin inhibitor minimization protocols in liver transplantation | 2009 | 41 | 52 | 52% |
Early use of renal-sparing agents in liver transplantation: A closer look | 2013 | 6 | 38 | 74% |
Calcineurin inhibitors in liver transplantation still champions or threatened by serious competitors? | 2013 | 4 | 41 | 83% |
Management of renal dysfunction in the liver transplant recipient | 2009 | 19 | 41 | 71% |
Everolimus in liver transplantation | 2014 | 1 | 15 | 80% |
Posttransplant Metabolic Syndrome: An Epidemic Waiting to Happen | 2009 | 53 | 45 | 33% |
Renal dysfunction in liver transplant recipients: Evaluation of the critical issues | 2012 | 14 | 61 | 44% |
Immunosuppression in liver transplant recipients with renal impairment | 2011 | 8 | 86 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERDISCIPLINARY LIVER TRANSPLANT UNIT | 3 | 40% | 0.5% | 6 |
2 | ADULT HLTH POST PROGRAM | 2 | 44% | 0.3% | 4 |
3 | BAYLOR TRANSPLANT SCI | 2 | 67% | 0.2% | 2 |
4 | DAI MED SPERIMENTALE PATOL | 2 | 67% | 0.2% | 2 |
5 | DAI NEFROUROL | 2 | 67% | 0.2% | 2 |
6 | LIVER GASTROINTESTINAL TRANSPLANT LIM 37 | 2 | 67% | 0.2% | 2 |
7 | SIBLEY MEM HOSP | 2 | 67% | 0.2% | 2 |
8 | ABDOMINAL ORGAN TRANSPLANTAT SURG | 1 | 100% | 0.2% | 2 |
9 | DAI MALATTIE PARATO DIGERENTE ENDOSCOPIA DIGE | 1 | 100% | 0.2% | 2 |
10 | ORGAN TRANSPLANT UNIT PARIDE STEFANINI | 1 | 27% | 0.3% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000147129 | SIROLIMUS//EVEROLIMUS//PROLIFERATION SIGNAL INHIBITORS |
2 | 0.0000122384 | HEPATITIS C RECURRENCE//RECURRENT HEPATITIS C//HCV RECURRENCE |
3 | 0.0000118351 | FK 506//FUJISAWA AMER//FUJISAWA AMER INC |
4 | 0.0000110271 | REG REFERENCE IMMUNOGENET TRANSPLANTAT IMMU//GRAFT ISCHEMIC TIME//HLA MATCHMAKER |
5 | 0.0000100654 | HEPATORENAL SYNDROME//TERLIPRESSIN//ASCITES |
6 | 0.0000092978 | MELD//MODEL FOR END STAGE LIVER DISEASE//DONOR RISK INDEX |
7 | 0.0000092797 | LYMPHOCYTOTOXIC CROSSMATCH//ANNETTE C HAROLD C SIMMONS TRANSPLANT//LIVER ALLOGRAFT REJECTION |
8 | 0.0000092484 | POSTTRANSPLANT HYPERLIPIDEMIA//ABT LEBENSMITTELSICHERHEIT 1//APOLIPOPROTEIN DISTRIBUTION |
9 | 0.0000091301 | CYCLOSPORINE A//CYCLOSPORINE NEPHROTOXICITY//NEPHROL HEM HE E TRANSPLANTAT |
10 | 0.0000090849 | POST TRANSPLANT DIABETES MELLITUS//NODAT//NEW ONSET DIABETES AFTER TRANSPLANTATION |